Skip to main content

Table 4 Serum SAA Levels in Benign Disease, CIN, and CC Patients

From: Expression of serum amyloid A in uterine cervical cancer

Group

Number

Median

NNL

32

9.2

CIN

34

14.1

Stage I

33

22.7

Stage II

39

24.3

Adenocarcinoma

6

20.2

Squamous cell carcinoma

66

25.9

Pairwise Comparison

 

P

NNL versus CIN

 

0.31

NNL versus stage I

 

0.002

CIN versus stage I

 

0.024

Stage I versus stage II

 

0.483

Adenocarcinoma and squamous cell carcinoma

 

0.626

  1. NNL Indicates non-neoplastic lesion; CIN Indicates cervical intraepithelial neoplasias; CC Cervical carcinoma; SD, Standard deviation; P Values are from 2-sided Wilcoxon-Kruskal-Wallis tests for the indicated comparisons.